The Norwegian Cerebral Venous Thrombosis Study
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorUniversity Hospital, Akershus
About this trial
The NoCVT study will investigate CVT (2014-2023) in a large Norwegian population (\> 3 millions) using several approaches combining existing health registries, clinical databases and new prospectively collected clinical data to explore epidemiology, risk factors, diagnostics, treatment, and the long-term prognosis of CVT.
Eligibility criteria
Qualifiers
A diagnosis of CVT 2014-2023 from the 13 participating primary hospitals
Disqualifiers
none
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Locations
1Map coordinates are unavailable for these locations. Locations are shown below instead.
Akershus University HospitalRecruiting1478, Lørenskog
Norway
NorwaySponsors and collaborators
University Hospital, Akershus
Lead sponsor
Oslo University Hospital
Collaborator
Haukeland University Hospital
Collaborator
Drammen sykehus
Collaborator
Sorlandet Hospital HF
Collaborator
St. Olavs Hospital
Collaborator
Nordlandssykehuset HF
Collaborator
University Hospital of North Norway
Collaborator
University of Oslo
Collaborator
Rigshospitalet, Denmark
Collaborator
Hospital de Santa Maria, Portugal
Collaborator
Sykehuset Innlandet HF
Collaborator
Molde Hospital
Collaborator
Helse Stavanger HF
Collaborator
Sykehuset Telemark
Collaborator
Sykehuset i Vestfold HF
Collaborator
Source ClinicalTrials.gov